Article Details
Retrieved on: 2022-11-29 07:35:11
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(Reuters) - AstraZeneca said on Tuesday it would acquire Neogene Therapeutics, a targeted cancer therapy developer, for up to $320 million, ...
Article found on: www.saltwire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here